ClinicalTrials.gov
ClinicalTrials.gov Menu

Spironolactone for Pulmonary Arterial Hypertension

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01712620
Recruitment Status : Recruiting
First Posted : October 23, 2012
Last Update Posted : July 6, 2018
Sponsor:
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
University of Pennsylvania
University of Maryland
Washington Hospital Center
New England Medical Center, Tufts University School of Medicine
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : October 1, 2021
  Estimated Study Completion Date : December 21, 2021
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):